Comparison of Immunosorbent Assays for the Quantification of Biomarkers for Alzheimer’s Disease in Human Cerebrospinal Fluid

Publisher： Karger

E-ISSN： 1421-9824|31|2|139-145

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.31, Iss.2, 2011-02, pp. : 139-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 33, Iss. 1, 2012-02 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Neuropsychiatric Correlates of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 6, 2008-06 ,pp. : 559-563

Karger

Access to resources Recommend Favorite

A Comparison of the Diagnostic Sensitivity of MRI, CBF-SPECT, FDG-PET and Cerebrospinal Fluid Biomarkers for Detecting Alzheimer’s Disease in a Memory Clinic

By  

Dementia and Geriatric Cognitive Disorders, Vol. 30, Iss. 4, 2010-09 ,pp. : 285-292

Karger

Access to resources Recommend Favorite

A Novel Panel of Cerebrospinal Fluid Biomarkers for the Differential Diagnosis of Alzheimer’s Disease versus Normal Aging and Frontotemporal Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 6, 2007-10 ,pp. : 434-440

Karger

Access to resources Recommend Favorite

Measurement of Laminins in the Cerebrospinal Fluid Obtained from Patients with Alzheimer’s Disease and Vascular Dementia Using a Modified Enzyme-Linked Immunosorbent Assay

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 3, 2002-09 ,pp. : 113-122

Karger

Access to resources Recommend Favorite